774243-35-5

Usage

Uses

Used in Pharmaceutical Industry:
3-ThioMorpholinecarboxylic acid, 2,2-diMethyl-, (3R)is used as a building block in the synthesis of pharmaceuticals for its unique chemical properties and versatile structure. It contributes to the development of various pharmaceutical products.
Used in Agrochemical Industry:
3-ThioMorpholinecarboxylic acid, 2,2-diMethyl-, (3R)is also used as a building block in the synthesis of agrochemicals, playing a role in the development of products for agricultural applications. Its unique structure and properties make it a valuable component in this industry as well.

Upstream product

• 79-37-8 oxalyl dichloride 
• 1113-41-3 L-penicillamine 
• 107-06-2 1,2-dichloro-ethane 

Downstream Products

• 774243-36-6 C₂₂H₂₅NO₄S 

Relevant academic research and scientific papers

CARBORANE HYDROXAMIC ACID MATRIX METALLOPROTEINASE AGENTS FOR BORON NEUTRON CAPTURE THERAPY

Disclosed herein are novel carborane hydroxamic acid matrix metalloproteinase ("MMP") agents bearing borane-containing moieties and methods for their use in treating or preventing a disease, such as cancer and rheumatoid arthritis. In particular, disclosed herein are compounds of Formula (I) and (II) and pharmaceutically acceptable salt thereof: wherein the substituents are as described.

Phosphate/sulfate ester compounds and pharmaceutical composition for inhibiting protein interacting NIMA (PIN1)

Phosphate/sulfate ester compounds that modulate and/or inhibit the activity of protein interacting NIMA (PIN1), and to pharmaceutical compositions containing such compounds are described. The invention is also directed to the therapeutic or prophylactic use of such compounds and compositions, and to methods of treating disorders characterized by hypertension, inappropriate cell proliferation, infectious diseases, and neurodegenerative brain disorders, by administering effective amounts of such compounds.

PHOSPHATE/SULFATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PROTEIN INTERACTING NIMA (PIN1)

Phosphate/sulfate ester compounds that modulate and/or inhibit the activity of protein interacting NIMA (PIN1), and to pharmaceutical compositions containing such compounds are described. The invention is also directed to the therapeutic or prophylactic use of such compounds and compositions, and to methods of treating disorders characterized by hypertension, inappropriate cell proliferation, infectious diseases, and neurodegenerative brain disorders, by administering effective amounts of such compounds.

ACETYLENIC ALPHA-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS

Compound of the formula (B) are useful in treating disease conditions mediated by TNF- alpha , such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and degenerative cartilage loss.